Literature DB >> 2040313

Validity of clinical diagnosis of heart failure in primary health care.

J Remes1, H Miettinen, A Reunanen, K Pyörälä.   

Abstract

Validity of heart failure (HF) diagnosis was studied in 88 patients (37 men and 51 women), aged 45-74 (mean 61) years, in whom HF diagnosis had been newly made by primary health care physicians. Boston criteria for HF and a supplementary classification, based on information from clinical examinations and a 6-month follow-up, were used to define HF diagnosis as 'definite', 'possible' or 'unlikely'. Twenty-eight (32%) patients (21 men and seven women) had 'definite' HF and 46 (52%) (28 men and 18 women) had either 'definite' or 'possible' HF by both classifications. In 30 (34%) patients (six men and 24 women) HF diagnosis was 'unlikely' by both classifications. In conclusion, false-positive diagnosis of HF was common in primary health care, and HF diagnosis was more difficult in women than in men. Obesity, unrecognized symptomatic myocardial ischaemia without HF and pulmonary diseases were the most important conditions leading to false-positive HF diagnosis.

Entities:  

Mesh:

Year:  1991        PMID: 2040313     DOI: 10.1093/oxfordjournals.eurheartj.a059896

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  96 in total

1.  The scale of heart failure: diagnosis and management issues for primary care.

Authors:  F D Hobbs
Journal:  Heart       Date:  1999-12       Impact factor: 5.994

Review 2.  Central role of echocardiography in the diagnosis and assessment of heart failure. British Society of Echocardiography.

Authors:  M G Cheesman; G Leech; J Chambers; M J Monaghan; P Nihoyannopoulos
Journal:  Heart       Date:  1998-11       Impact factor: 5.994

Review 3.  Clinical case studies in heart failure management.

Authors:  R J MacFadyen; P Shiels; A D Struthers
Journal:  Br J Clin Pharmacol       Date:  1999-03       Impact factor: 4.335

Review 4.  Towards a blood test for heart failure: the potential use of circulating natriuretic peptides.

Authors:  S Talwar; P F Downie; L L Ng; I B Squire
Journal:  Br J Clin Pharmacol       Date:  2000-07       Impact factor: 4.335

5.  Modern management of hypertension and heart failure: evidence and practice.

Authors:  F D Hobbs
Journal:  Heart       Date:  2000-09       Impact factor: 5.994

6.  Determinants of locomotor disability in people aged 55 years and over: the Rotterdam Study.

Authors:  E Odding; H A Valkenburg; H J Stam; A Hofman
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

7.  The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure.

Authors:  Ahmet Fuat; Jeremy J Murphy; A Pali S Hungin; Jane Curry; Ali A Mehrzad; Andrew Hetherington; Jennifer I Johnston; W Stuart A Smellie; Victoria Duffy; Patricia Cawley
Journal:  Br J Gen Pract       Date:  2006-05       Impact factor: 5.386

8.  Perindopril improves six minute walking distance in older patients with left ventricular systolic dysfunction: a randomised double blind placebo controlled trial.

Authors:  S D Hutcheon; N D Gillespie; I K Crombie; A D Struthers; M E T McMurdo
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

9.  Role of echocardiography in the evaluation of syncope: a prospective study.

Authors:  F P Sarasin; A-F Junod; D Carballo; S Slama; P-F Unger; M Louis-Simonet
Journal:  Heart       Date:  2002-10       Impact factor: 5.994

10.  Survival differences between heart failure in general practices and in hospitals.

Authors:  O Wendelboe Nielsen; J Hilden; T McDonagh; J Fischer Hansen
Journal:  Heart       Date:  2003-11       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.